434
Views
11
CrossRef citations to date
0
Altmetric
Short Communication

Serum S100 protein could predict altered consciousness in glyphosate or glufosinate poisoning patients

, , , , &
Pages 357-359 | Received 06 Sep 2016, Accepted 12 Jan 2017, Published online: 16 Mar 2017

References

  • Inoue Y, Onodera M, Fujita Y, et al. Factors associated with severe effects following acute glufosinate poisoning. Clin Toxicol. 2013;51:846–849.
  • Roberts DM, Buckley NA, Mohamed F, et al. A prospective observational study of the clinical toxicology of glyphosate-containing herbicides in adults with acute self-poisoning. Clin Toxicol. 2010;48:129–136.
  • Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun. 1965;19:739–744.
  • Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal nonnervous human tissues. Lab Invest. 1987;57:489–498.
  • Ambrozic J, Bunc M, Osredkar J, et al. S100B protein in benzodiazepine overdose. Emerg Med J. 2008;25:90–92.
  • Yardan T, Baydin A, Acar E, et al. The role of serum cholinesterase activity and S100B protein in the evaluation of organophosphate poisoning. Hum Exp Toxicol. 2013;32:1081–1088.
  • Akdemir HU, Yardan T, Kati C, et al. The role of S100B protein, neuron-specific enolase, and glial fibrillary acidic protein in the evaluation of hypoxic brain injury in acute carbon monoxide poisoning. Hum Exp Toxicol. 2014;33:1113–1120.
  • Persson HE, Sjoberg GK, Haines JA, et al. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol. 1998;36:205–213.
  • Foerch C, Singer OC, Neumann-Haefelin T, et al. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol. 2005;62:1130–1134.
  • Yoon SM, Choi YJ, Kim HJ, et al. Prognostic value of serum s100 protein by elecsys s100 immunoassay in patients with spontaneous subarachnoid and intracerebral hemorrhages. J Korean Neurosurg Soc. 2008;44:308–313.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.